Snapshot from Aug 24, 2026 at 07:00 UTC. For live data and tracking: View Live
Person

Karen Knudsen

Tracked across 2 events · 109 articles · First seen Apr 17, 2026 · Last active Aug 20, 2026

Sentiment
45
Attention
8
Events
2
Relationships
0
Live sentiment trends, attention charts, and prominence tracking available on the Ergen Dashboard
2 40
Business
Impact: Karen Knudsen is the CEO of SAGT, expressing commitment to sustainable growth and operational excellence.
Jul 20, 2026 · 7 articles
8 50
Tech
Moderna and Merck & Co. announced on August 19, 2026, that their personalized mRNA cancer vaccine, Intismeran, combined with Merck's immunotherapy drug Pembrolizumab, met its primary and secondary goals in a Phase 3 trial for…
Impact: As CEO of Parker Institute, Knudsen said the results signal a new era for solid-tumor cancer treatment.
Aug 19, 2026 · 102 articles
ERGEN INTELLIGENCE
Track Karen Knudsen live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.